No survival impact was found for PTPN11 mutations in previous studies [37,82], but according to the study of Makishima H et al., these gene mutations are associated with faster disease progression to AML and a lower overall survival time [44]. This evidence concerns the gene PTPN11 and acute myeloid leukemia.